Featured News

Thank you to Provention Bio, Inc., for supporting our upcoming Patient Education and Advocacy Summit. Provention Bio, Inc., is a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. Register now to be a part of this monumental event!

Thank you to Schär for sponsoring our upcoming Patient Education and Advocacy Summit. For over 35 years, Schär has been dedicated to the celiac and gluten-sensitive communities by providing a safe, flavorful, and quality line of gluten-free products. Learn more about Schär’s collection of gluten-free goods.

Initial findings of the first mass screening study for U.S. children show a high prevalence of celiac disease autoimmunity (CDA) among those without symptoms and no family history of the condition.

I want to share with you highlights of our advocacy plans for 2021. Our work in Washington, DC, with Congress, with the NIH, FDA, and other agencies, is critical in the pursuit of treatments and a cure for celiac disease.

The Senate Appropriations Committee has released their FY2021 funding recommendations, which includes report language directing NIH to support celiac disease research.

The Celiac Disease Foundation achieved a number of critical milestones in 2020 in our efforts to accelerate the development of treatments and a cure for celiac disease.

Patients Who Have Participated In a Celiac Disease Clinical Trial Needed for 2021 Patient Education & Advocacy Summit.

A new intensive study confirms that people with celiac disease are frequently exposed to gluten in food.

On November 14 and 15, more than 2,500 supporters from 48 states and seven countries laced up to move 3.1 miles (5K) “across the country” for a cure at the CDF Virtual Turkey Trot. This monumental event raised more than $184,000 for celiac disease research.

The Celiac Disease Foundation’s article, “How Nonprofits Can Make Their Virtual Fundraisers a Success” was featured in the Digestive Health and Wellness section of their website.